Entellus Medical Inc (ENTL) Stock Formed Double Bottom Pattern. What To Expect?

June 19, 2017 - By reb123z

The chart of Entellus Medical Inc (ENTL) shows a double bottom with $13.51 target or 5.00 % below today’s $14.22 share price. The 5 months chart pattern indicates high risk for the $315.65 million company. It was reported on Jun, 19 by Finviz.com. If the $13.51 price target is reached, the company will be worth $15.78M less. Double bottoms are rare but powerful chart patterns.

It closed at $14.22 lastly. It is down 17.59% since June 19, 2016 and is downtrending. It has underperformed by 34.29% the S&P500.

Analysts expect Entellus Medical Inc (NASDAQ:ENTL) to report $-0.23 EPS on August, 2.They anticipate $0.04 EPS change or 14.81 % from last quarter’s $-0.27 EPS. After having $-0.40 EPS previously, Entellus Medical Inc’s analysts see -42.50 % EPS growth.

Entellus Medical Inc (NASDAQ:ENTL) Ratings Coverage

Among 3 analysts covering Entellus Medical (NASDAQ:ENTL), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Entellus Medical has $27 highest and $22 lowest target. $25.25’s average target is 77.57% above currents $14.22 stock price. Entellus Medical had 5 analyst reports since August 9, 2015 according to SRatingsIntel. As per Tuesday, June 14, the company rating was initiated by BTIG Research. The stock of Entellus Medical Inc (NASDAQ:ENTL) has “Buy” rating given on Sunday, August 9 by Canaccord Genuity. Piper Jaffray maintained the shares of ENTL in report on Tuesday, September 29 with “” rating. Deutsche Bank initiated Entellus Medical Inc (NASDAQ:ENTL) on Thursday, October 6 with “Buy” rating.

More notable recent Entellus Medical Inc (NASDAQ:ENTL) news were published by: Globenewswire.com which released: “Entellus Medical to Present at the William Blair Growth Stock Conference” on June 01, 2017, also Marketwatch.com with their article: “14.22” published on January 29, 2015, Tcbmag.com published: “Entellus Medical Nets $37M In Stock Sale” on February 01, 2017. More interesting news about Entellus Medical Inc (NASDAQ:ENTL) were released by: Globenewswire.com and their article: “Entellus Medical Announces Fourth Quarter and Full Year 2016 Financial Results” published on February 21, 2017 as well as Globenewswire.com‘s news article titled: “Entellus Medical Acquires XeroGelâ„¢ from CogENT Therapeutics®, Strengthens …” with publication date: June 29, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.